Interleukin‐2 receptor expression in benign and malignant melanocytic skin lesions
- 1 April 1989
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 157 (4) , 315-319
- https://doi.org/10.1002/path.1711570408
Abstract
The immunophenotype of the lymphocytic reaction of melanocytic skin lesions (12 cases of cutaneous malignant melanoma (CMM), three of Hutchinson's melanotic freckle (HMF), and eight naevocellular naevi) has been studied using monoclonal antibodies. CMM was associated with the most intense lymphocytic reaction, the lymphocytes being T cells of both CD‐4 T helper/inducer and CD‐8 suppressor/cytotoxic subsets which were present in varying proportions. Although less marked, the lymphocytic reaction to HMF and benign naevi showed similar features. An antibody to the interleukin‐2 receptor (IL‐2R; Tac, CD‐25) was included in the panel and the earlier findings of positively stained cells in association with CMM were confirmed. In addition, the novel finding of these cells in association with HMF and naevocellular naevi is reported. The number of these CD‐25 positive cells was extremely variable but they appeared most prominent in association with CMM. The findings presented here indicate that it is not possible to infer that CD‐25 positive lymphocytes present in the host response to CMM necessarily indicates tumour specific activation of the cells of the host immune system.Keywords
This publication has 21 references indexed in Scilit:
- Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomasVirchows Archiv, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Phenotypic identification of mononuclear cells in oral premalignant lesions and cancer by monoclonal antibodiesJournal of Oral Pathology & Medicine, 1986
- The Structure, Function, and Expression of Interleukin-2 Receptors on Normal and Malignant LymphocytesScience, 1986
- The classification of malignant melanoma, its histological reporting and registration: a revision of the 1972 sydney classificationPathology, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- T cell subsets and Langerhans cells in skin tumoursEuropean Journal of Cancer and Clinical Oncology, 1983
- Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma.The Journal of Immunology, 1982
- Inhibition of endogenous tissue alkaline phosphatase with the use of alkaline phosphatase conjugates in immunohistochemistry.Journal of Histochemistry & Cytochemistry, 1981